NBC Chicago: Ford recalls more than 456,000 Bronco Sport and Maverick vehicles for battery problem

Ford Recalls Over 456,000 Bronco Sport and Maverick Vehicles for Battery Detection Issue

Ford is issuing a recall for over 456,000 Bronco Sport and Maverick vehicles due to a battery detection issue that can cause sudden stalling or an inability to restart, as well as the use of other electric capabilities like hazard lights. The recall covers about 403,000 model year 2021-2024 Bronco Sports produced between February 2020 and March 2024, as well as more than 53,000 model year 2022-2023 Mavericks manufactured from February 2021 to October 2022.

To address this issue, dealers will recalibrate the impacted vehicles’ body and power train control modules at no cost. Owner notification letters are set to be mailed out on May 13. The software update is not yet available, but should arrive by the end of the second quarter. In a statement, Ford emphasized that safety is their top priority and that they are taking proactive measures to address this issue promptly and effectively.

As of Feb. 8, the NHSTA recall report notes that Ford was not aware of any injuries tied to the issue — but there were 917 related warranty reports, 11 field reports, and 54 customer complaints. Additionally, there were two property damage claims and three unverified fire reports. This isn’t the only recall affecting Bronco Sport owners; last week, the NHTSA announced that they were investigating the remedy proposed by Ford after the recall of nearly 43,000 select Bronco Sport and Escape SUVs. In these vehicles, gasoline can leak from the fuel injectors onto hot engine surfaces, increasing the risk of fires. The NHTSA stated that the remedy proposed by Ford did not include repairing the fuel leaks.

Leave a Reply

Patriots Willing to Explore All Options With No. 3 Pick in NFL Draft, Including Quarterback Previous post Will the Patriots Take a Chance on a Rookie Quarterback in the First Round?
How weight-loss medications are set to transform the world Next post Breaking Down the Implications of New Weight Loss Drugs with The Economist Podcast